What is Mg12?
Mg12 operates at the intersection of sports science and natural wellness, specializing in the development of topical magnesium products designed to facilitate muscle recovery and systemic health support. The company's diverse catalog, which includes magnesium-infused salts, oils, balms, and soaps, addresses critical physiological needs such as muscle tension, anxiety, and performance-related fatigue. By targeting athletes and active individuals, Mg12 has carved out a distinct niche in the consumer health market, emphasizing efficacy and natural ingredient profiles. Their commitment to quality is further reinforced by a customer satisfaction guarantee, which has helped build brand loyalty among a demographic increasingly focused on holistic recovery methods.
How much funding has Mg12 raised?
Mg12 has raised a total of $32K across 1 funding round:
Debt
$32K
Debt (2021): $32K with participation from PPP
Key Investors in Mg12
PPP
Public-Private Partnership
What's next for Mg12?
With the recent infusion of capital, Mg12 is poised to accelerate its strategic roadmap, focusing on scaling distribution channels and enhancing its research and development capabilities. The company is expected to prioritize the expansion of its product line to address emerging trends in the wellness industry, potentially exploring new delivery mechanisms for its magnesium-based formulations. Furthermore, the firm will likely invest in marketing initiatives to broaden its reach beyond its core athletic demographic, tapping into the growing demand for natural pain management alternatives. As Mg12 continues to mature, the focus will remain on operational excellence and maintaining the high standards of product integrity that have defined its growth to date.
See full Mg12 company page
